Shares of Questcor Pharmaceuticals (NASDAQ: QCOR )
, a biopharmaceutical company focused on developing therapies to treat
autoimmune and inflammatory disorders, skyrocketed as much as 32% after
announcing this morning that it had agreed to be acquired by Mallinckrodt (NYSE: MNK ) .
Source: http://www.fool.com/investing/general/2014/04/07/why-questcor-pharmaceuticals-inc-shares-skyrockete.aspx
Source: http://www.fool.com/investing/general/2014/04/07/why-questcor-pharmaceuticals-inc-shares-skyrockete.aspx
No comments:
Post a Comment